EP4234546
IMPROVED SYNTHESIS OF KEY INTERMEDIATE OF KRAS G12C INHIBITOR COMPOUND
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
15.11.2019EP published:
15.4.2026EP application number:
23174717.1
EPO information:
European Patent Register
Max expiry date:
14.11.2039Expiry date:
14.11.2026
Title in English:
IMPROVED SYNTHESIS OF KEY INTERMEDIATE OF KRAS G12C INHIBITOR COMPOUNDLanguage of the patent:
English
Timeline
Today
15.11.2019EP application
15.4.2026EP Publication
14.11.2026Expires
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks CA 91320, US
Inventor
Name:
PARSONS, Andrew ThomasAddress:
Thousand Oaks, California, US
Name:
COCHRAN, Brian McNeilAddress:
Thousand Oaks, California, US
Name:
POWAZINIK, IV, WilliamAddress:
Thousand Oaks, California, US
Name:
CAPORINI, Marc AnthonyAddress:
Thousand Oaks, California, US
Priority
Number:
201862768802 PDate:
16.11.2018Country:
US
Classification
Categories:
C07D 401/04, C07D 401/14